Praxis Precision Medicines to Present at Stifel’s 4th Annual CNS Day

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) announced its participation in a fireside chat at Stifel’s 4th Annual CNS Day on March 29, 2022, at 11:30 a.m. ET. The event will be accessible through a live webcast on the company’s website, with a replay available for 90 days post-event. Praxis focuses on developing therapies for central nervous system disorders by leveraging genetic insights into neuronal excitation-inhibition imbalances, targeting both rare and prevalent neurological and psychiatric conditions. For more details, visit www.praxismedicines.com.

BOSTON, March 21, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in a fireside chat at Stifel’s 4^th Annual CNS Day on Tuesday, March 29, 2022 at 11:30 a.m. ET.

The fireside chat will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 90 days following the event.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across psychiatric disorders, movement disorders, epilepsy and other CNS indications, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

FAQ

What is the date and time of Praxis Precision Medicines' fireside chat?

The fireside chat is scheduled for March 29, 2022, at 11:30 a.m. ET.

Where can I watch the fireside chat for Praxis (PRAX)?

The fireside chat will be available via live webcast on the company's Investors + Media section of their website.

What is the main focus of Praxis Precision Medicines?

Praxis focuses on developing therapies for central nervous system disorders, particularly those related to neuronal excitation-inhibition imbalances.

How long will the replay of the fireside chat be available?

A replay of the webcast will be available for 90 days following the event.

What types of disorders does Praxis target?

Praxis targets both rare and prevalent neurological and psychiatric disorders.